Allarity Therapeutics Inc
Change company Symbol lookup
Select an option...
ALLR Allarity Therapeutics Inc
SIVB SVB Financial Group
LYLT Loyalty Ventures Inc
NMRD Nemaura Medical Inc
LOGI Logitech International SA
BIOC Biocept Inc
KT KT Corp
SVRA Savara Inc
KA Kineta Inc
IMNM Immunome Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company. The Company is engaged in targeting some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates together with its Drug Response Predictor (DRP) companion diagnostics in a precision medicine approach. The Company's products include dovitinib, stenoparib, and IXEMPRA (ixabepilone). The lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. The therapeutic candidate is stenoparib is a novel inhibitor of the key deoxyribonucleic acid (DNA) damage repair enzyme poly-ADP-ribose polymerase (PARP). The therapeutic candidate is IXEMPRA (ixabepilone) is a selective microtubule inhibitor. The DRP technology is a diagnostic platform that models human tumor biology and can help predict whether a cancer patient respond or not to a particular drug.

Closing Price
$0.1439
Day's Change
0.0389 (37.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.229
Day's Low
0.1301
Volume
(Heavy Day)
Volume:
83,434,571

10-day average volume:
8,156,624
83,434,571

NGA Awards Maxar Land Cover and Enhanced API Contracts

6:00 am ET January 4, 2023 (BusinessWire) Print

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), provider of comprehensive space solutions and secure, precise, geospatial intelligence, today announced new contract awards worth up to $35.8 million from the U.S. National Geospatial-Intelligence Agency (NGA).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230104005147/en/

The first award is a one-year Period of Performance contract worth up to $22.5 million with $11.3 million initially funded under NGA's Janus Geography program. This new award builds upon Maxar's more than 20 years of experience delivering foundational geospatial intelligence data to NGA by characterizing land cover at high resolution over numerous previously unmapped areas.

Under the second award, worth up to $13.3 million, Maxar will provide NGA's Foundation Program with a modern, enhanced application programming interface (API) capable of querying, discovering and downloading Maxar products derived from the company's 125-petabyte (PB) high-resolution commercial imagery archive. Additionally, this enhanced API will deliver content to the end user's cloud account rather than via legacy dissemination methods. Additional options include third-party content integration, full business analytics and greater production capacity.

The enhanced API award is for a performance period of up to 4.5 years consisting of a base of six months and four full option years. The new API will support computer vision, machine learning and artificial intelligence applications.

"Maxar is proud to continue partnering with NGA on enduring missions such as foundation geospatial intelligence, land cover and intelligence support, as well as to help spur innovation in new areas like automation," said Tony Frazier, Maxar's Executive Vice President and General Manager, Public Sector Earth Intelligence. "Public-private partnerships such as this represent the U.S. government's ongoing commitment to commercial space and geospatial analytics technology."

About Maxar Maxar Technologies (NYSE:MAXR) (TSX:MAXR) is a provider of comprehensive space solutions and secure, precise, geospatial intelligence. We deliver disruptive value to government and commercial customers to help them monitor, understand and navigate our changing planet; deliver global broadband communications; and explore and advance the use of space. Our unique approach combines decades of deep mission understanding and a proven commercial and defense foundation to deploy solutions and deliver insights with unrivaled speed, scale and cost-effectiveness. Maxar's 4,400 team members in over 20 global locations are inspired to harness the potential of space to help our customers create a better world. Maxar trades on the New York Stock Exchange and Toronto Stock Exchange as MAXR. For more information, visit www.maxar.com.

Forward-Looking Statements This press release may contain forward-looking statements that reflect management's current expectations, assumptions and estimates of future performance and economic conditions. Any such forward-looking statements are made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements, including those included in the Company's filings with U.S. securities and Canadian regulatory authorities. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as may be required under applicable securities law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230104005147/en/

SOURCE: Maxar Technologies

Investor Relations Contact: 
Jonny Bell
Maxar Investor Relations
1-303-684-5543
jonny.bell@maxar.com 


Media Contact: 
Brian Wagner
Maxar Communications
1-202-302-8754
Brian.wagner@maxar.com
comtex tracking

COMTEX_421899683/1006/2023-01-04T06:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.